Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Intern Emerg Med ; 17(8): 2367-2377, 2022 11.
Article in English | MEDLINE | ID: mdl-35918627

ABSTRACT

We tested the prognostic performance of different scores for the identification of subjects with acute respiratory failure by COVID-19, at risk of in-hospital mortality and NIV failure. We conducted a retrospective study, in the Medical High-Dependency Unit of the University-Hospital Careggi. We included all subjects with COVID-19 and ARF requiring non-invasive ventilation (NIV) between March 2020 and January 2021. Clinical parameters, the HACOR score (Heart rate, Acidosis, Consciousness, Oxygenation, Respiratory Rate) and ROX index ((SpO2/FiO2)/respiratory rate) were collected 3 (-3) and 1 day (-1) before the NIV initiation, the first day of treatment (Day0) and after 1 (+1), 2 (+2), 5 (+5), 8 (+8) and 11 (+11) of treatment. The primary outcomes were in-hospital mortality and NIV failure. We included 135 subjects, mean age 69±13 years, 69% male. Patients, who needed mechanical ventilation, showed a higher HACOR score (Day0: 6 [5-7] vs 6 [6-7], p=.057; Day+2: 6 [6-6] vs 6 [4-6], p=.013) and a lower ROX index (Day0: 4.2±2.3 vs 5.1±2.3, p=.055; Day+2: 4.4±1.2.vs 5.5±1.3, p=.001) than those with successful NIV. An HACOR score >5 was more frequent among nonsurvivors (Day0: 82% vs 58%; Day2: 82% vs 48%, all p<0.01) and it was associated with in-hospital mortality (Day0: RR 5.88, 95%CI 2.01-17.22; Day2: RR 4.33, 95%CI 1.64-11.41) independent to age and Charlson index. In conclusion, in subjects treated with NIV for ARF caused by COVID19, respiratory parameters collected after the beginning of NIV allowed to identify those at risk of an adverse outcome. An HACOR score >5 was independently associated with increased mortality rate.


Subject(s)
COVID-19 , Noninvasive Ventilation , Respiratory Insufficiency , Adult , Humans , Male , Middle Aged , Aged , Aged, 80 and over , Female , Noninvasive Ventilation/adverse effects , Respiration, Artificial , Hospital Mortality , COVID-19/therapy , Retrospective Studies , Respiratory Insufficiency/therapy , Respiratory Insufficiency/etiology , Prognosis
2.
Open Access Emerg Med ; 13: 465-479, 2021.
Article in English | MEDLINE | ID: mdl-34795538

ABSTRACT

In the Emergency Medicine setting, D-dimer is currently employed in the diagnostic assessment of suspected venous thromboembolism and aortic syndrome. The nonspecific symptoms reported by patients, like chest pain, dyspnea or syncope, uncover a wide range of differential diagnosis, spanning from mild to life-threatening conditions. Therefore, we assumed the perspective of the Emergency Physician and, in this narrative review, we reported a brief presentation of the epidemiology of these symptoms and the characteristics of patients, in whom we could suspect the aforementioned pathologies. We also reported in which patients D-dimer gives useful information. In fact, when the probability of the disease is high, the D-dimer level is futile. On the contrary, given the low specificity of the test, when the probability of the disease is very low, a false-positive value of the D-dimer only increases the risk of overtesting. Patients with low to moderate probability really benefit from the D-dimer testing, in order to prevent the execution of expensive and potentially dangerous imaging tests. In the second part of the review, we focused on the prognostic value of the test in septic patients. The early prognostic stratification of septic patients remains a challenge for the Emergency Physician, in the absence of a definite biomarker or score to rely on. Therefore, we need several parameters for the early identification of patients at risk of an adverse prognosis and the D-dimer may play a role in this demanding task. SARS COVID-19 patients represent an emerging reality, where the role of the D-dimer for prognostic stratification could be relevant. In fact, in patients with severe forms of this disease, the D-dimer reaches very high values, which appear to parallel the course of respiratory failure. Whether the test may add useful information for the management of these patients remains to be determined.

3.
Neurobiol Aging ; 36(2): 877-85, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25453559

ABSTRACT

Accumulation of amyloid-ß (Aß) peptides correlates with aging and progression of Alzheimer's disease (AD). Aß peptides, which cause early synaptic dysfunctions, spine loss, and memory deficits, also disturb intracellular Ca(2+) homeostasis. By cytosolic and endoplasmic reticulum Ca(2+) measurements, we here define the short-term effects of synthetic Aß42 on neuronal Ca(2+) dynamics. When applied acutely at submicromolar concentration, as either oligomers or monomers, Aß42 did not cause Ca(2+) release or Ca(2+) influx. Similarly, 1-hour treatment with Aß42 modified neither the resting cytosolic Ca(2+) level nor the long-lasting Ca(2+) influx caused by KCl-induced depolarization. In contrast, Aß42 oligomers, but not monomers, significantly altered Ca(2+) release from stores with opposite effects on inositol 1,4,5-trisphosphate (IP3)- and caffeine-induced Ca(2+) mobilization without alteration of the total store Ca(2+) content. Ca(2+) dysregulation by Aß42 oligomers involves metabotropic glutamate receptor 5 and requires network activity and the intact exo-endocytotic machinery, being prevented by tetrodotoxin and tetanus toxin. These findings support the idea that Ca(2+) store dysfunction is directly involved in Aß42 neurotoxicity and represents a potential therapeutic target in AD-like dementia.


Subject(s)
Alzheimer Disease/etiology , Amyloid beta-Peptides/physiology , Amyloid beta-Peptides/toxicity , Calcium/metabolism , Cytosol/metabolism , Neurons/metabolism , Peptide Fragments/physiology , Peptide Fragments/toxicity , Alzheimer Disease/therapy , Animals , Cells, Cultured , Endoplasmic Reticulum/metabolism , Fura-2 , Humans , Mice, Inbred C57BL , Molecular Targeted Therapy , Polymerization , Potassium Chloride/pharmacology , Rats , Receptor, Metabotropic Glutamate 5/physiology , Structure-Activity Relationship
4.
Aging Cell ; 11(5): 885-93, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22805202

ABSTRACT

Mutations in amyloid precursor protein (APP), and presenilin-1 and presenilin-2 (PS1 and PS2) have causally been implicated in Familial Alzheimer's Disease (FAD), but the mechanistic link between the mutations and the early onset of neurodegeneration is still debated. Although no consensus has yet been reached, most data suggest that both FAD-linked PS mutants and endogenous PSs are involved in cellular Ca2+ homeostasis. We here investigated subcellular Ca2+ handling in primary neuronal cultures and acute brain slices from wild type and transgenic mice carrying the FAD-linked PS2-N141I mutation, either alone or in the presence of the APP Swedish mutation. Compared with wild type, both types of transgenic neurons show a similar reduction in endoplasmic reticulum (ER) Ca2+ content and decreased response to metabotropic agonists, albeit increased Ca2+ release induced by caffeine. In both transgenic neurons, we also observed a higher ER-mitochondria juxtaposition that favors increased mitochondrial Ca2+ uptake upon ER Ca2+ release. A model is described that integrates into a unifying hypothesis the contradictory effects on Ca2+ homeostasis of different PS mutations and points to the relevance of these findings in neurodegeneration and aging.


Subject(s)
Calcium/metabolism , Neurons/metabolism , Presenilin-2/biosynthesis , Alzheimer Disease , Amyloid beta-Protein Precursor/biosynthesis , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , Disease Models, Animal , Endoplasmic Reticulum/genetics , Endoplasmic Reticulum/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Mice , Mice, Transgenic , Mitochondria/genetics , Mitochondria/metabolism , Neurons/drug effects , Presenilin-2/genetics , Presenilin-2/metabolism , Ryanodine/metabolism
5.
J Proteome Res ; 11(2): 523-36, 2012 Feb 03.
Article in English | MEDLINE | ID: mdl-22023170

ABSTRACT

Approximately 25% of eukaryotic proteins possessing homology to at least two transmembrane domains are predicted to be embedded in biological membranes. Nevertheless, this group of proteins is not usually well represented in proteome-wide experiments due to their refractory nature. Here we present a quantitative mass spectrometry-based comparison of membrane protein expression in cerebellar granule neurons grown in primary culture that were isolated from wild-type mice and mice lacking the cellular prion protein. This protein is a cell-surface glycoprotein that is mainly expressed in the central nervous system and is involved in several neurodegenerative disorders, though its physiological role is unclear. We used a low specificity enzyme α-chymotrypsin to digest membrane proteins preparations that had been separated by SDS-PAGE. The resulting peptides were labeled with tandem mass tags and analyzed by MS. The differentially expressed proteins identified using this approach were further analyzed by multiple reaction monitoring to confirm the expression level changes.


Subject(s)
Cerebellum/chemistry , Membrane Proteins/analysis , Neurons/chemistry , PrPC Proteins/deficiency , Proteome/analysis , Amino Acid Sequence , Animals , Cells, Cultured , Cerebellum/cytology , Cerebellum/metabolism , Electrophoresis, Polyacrylamide Gel , Membrane Proteins/classification , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Knockout , Molecular Sequence Data , Neurons/metabolism , Peptide Fragments/analysis , PrPC Proteins/genetics , PrPC Proteins/metabolism , Proteome/genetics , Proteome/metabolism , Proteomics , Reproducibility of Results , Tandem Mass Spectrometry
6.
J Neurochem ; 116(5): 881-90, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21214552

ABSTRACT

The cellular prion protein (PrP(C)) is a cell-surface glycoprotein mainly expressed in the CNS. The structural conversion of PrP(C) generates the prion, the infectious agent causing transmissible spongiform encephalopathies, which are rare and fatal diseases affecting animals and humans. Despite decades of intensive research, the mechanism of prion-associated neurodegeneration and the physiologic role of PrP(C) are still obscure. Recent evidence, however, supports the hypothesis that PrP(C) may be involved in the control of Ca(2+) homeostasis. Given the universal significance of Ca(2+) as an intracellular messenger for both the life and death of cells, this possibility may help explain the complex, often controversial, dataset accumulated on PrP(C) physiology, and the events leading to prion-associated neuronal demise. In this study, we have compared local Ca(2+) movements in cerebellar granule neurons (CGN) derived from wild-type (WT), or PrP-knockout (KO), mice, by means of the Ca(2+)-sensitive photo-probe, aequorin, genetically targeted to specific intracellular domains and delivered to CGN by lentiviral vectors. The use of an aequorin that localizes to the cytosolic domains proximal to the plasma membrane has allowed us to demonstrate that there was a dramatic increase of store-operated Ca(2+) entry in PrP-KO CGN compared to WT neurons. Notably, this phenotype was rescued upon restoring PrP(C) expression. The Ca(2+)-phenotype of PrP-KO neurons can in part be explained by the lower expression of two major Ca(2+)-extruding proteins, namely the plasma membrane and the sarco-endoplasmic reticulum Ca(2+)-ATPases. The lower sarco-endoplasmic reticulum Ca(2+)-ATPase content may also contribute to explain why PrP-KO CGN accumulated less Ca(2+) in the endoplasmic reticulum than the WT counterpart.


Subject(s)
Calcium/metabolism , Cerebellum/cytology , Neurons/metabolism , PrPC Proteins/metabolism , Prions/metabolism , Aequorin/metabolism , Animals , Antibodies/pharmacology , Calcium Channels/metabolism , Cell Membrane/genetics , Cell Membrane/metabolism , Cells, Cultured , Endoplasmic Reticulum/metabolism , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Mice , Mice, Transgenic , Neurons/cytology , ORAI2 Protein , PrPC Proteins/deficiency , PrPC Proteins/immunology , Prion Proteins , Prions/genetics , Prions/immunology , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Transfection/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...